Urinary tract infection resident survival guide: Difference between revisions
Jump to navigation
Jump to search
Ochuko Ajari (talk | contribs) |
Ochuko Ajari (talk | contribs) No edit summary |
||
(7 intermediate revisions by 4 users not shown) | |||
Line 1: | Line 1: | ||
<div style="width: 1px; height: 1px; background-color: #999999; position: fixed; top: 10px; left: 10px"></div> | |||
<div style="width: 90%; -webkit-user-select: none;"> | |||
{| class="infobox" style="margin: 0 0 0 0; border: 0; float: right; width: 5%; background: #A8A8A8; position: fixed; top: 250px; right: 20px; border-radius: 10px 10px 10px 10px;" cellpadding="0" cellspacing="0" ; | |||
|- | |||
! style="padding: 0 5px; font-size: 80%; background: #A8A8A8;" align="center" | {{fontcolor|#2B3B44|Urinary tract infection<BR>Resident Survival Guide}} | |||
|- | |||
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC; border-radius: 5px 5px 5px 5px;" align="left" | [[{{PAGENAME}}#Overview|Overview]] | |||
|- | |||
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC; border-radius: 5px 5px 5px 5px;" align="left" | [[{{PAGENAME}}#Causes|Causes]] | |||
|- | |||
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC; border-radius: 5px 5px 5px 5px;" align="left" | [[{{PAGENAME}}#Complete Diagnostic Approach|Diagnosis]] | |||
|- | |||
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC; border-radius: 5px 5px 5px 5px;" align="left" | [[{{PAGENAME}}#Treatment|Treatment]] | |||
|- | |||
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC; border-radius: 5px 5px 5px 5px;" align="left" | [[{{PAGENAME}}#Do's|Do's]] | |||
|- | |||
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC; border-radius: 5px 5px 5px 5px;" align="left" | [[{{PAGENAME}}#Don'ts|Don'ts]] | |||
|} | |||
__NOTOC__ | __NOTOC__ | ||
{{CMG}}; {{AE}} {{Ochuko}} | |||
{{CMG}}; {{AE}} {{Ochuko}} {{IQ}} | |||
==Overview== | ==Overview== | ||
Line 7: | Line 26: | ||
==Causes== | ==Causes== | ||
===Life Threatening Causes=== | ===Life Threatening Causes=== | ||
Life-threatening causes include conditions which may result in death or permanent disability within 24 hours if left untreated. | * Life-threatening causes include conditions which may result in death or permanent disability within 24 hours if left untreated. | ||
Urinary tract infection does not have life threatening causes. | * Urinary tract infection does not have life threatening causes. | ||
===Common Causes=== | ===Common Causes=== | ||
Line 34: | Line 53: | ||
{{familytree | | | | D01 | | | | | | | | | | | | D01=<div style="float: left; text-align: left; line-height: 150% "> '''Order tests:'''<br> ❑ [[Urine culture]] <br> ❑ [[Urinalysis]] <br> ❑ [[Blood culture]] <br> ❑ [[CT|Abdominal CT]] <br> ❑ [[ultrasound|Renal ultrasound scan]] <br> ❑ [[Voiding cystourethrogram]] <br> ❑ [[Intravenous pyelogram]]</div>}} | {{familytree | | | | D01 | | | | | | | | | | | | D01=<div style="float: left; text-align: left; line-height: 150% "> '''Order tests:'''<br> ❑ [[Urine culture]] <br> ❑ [[Urinalysis]] <br> ❑ [[Blood culture]] <br> ❑ [[CT|Abdominal CT]] <br> ❑ [[ultrasound|Renal ultrasound scan]] <br> ❑ [[Voiding cystourethrogram]] <br> ❑ [[Intravenous pyelogram]]</div>}} | ||
{{familytree/end}} | {{familytree/end}} | ||
Line 57: | Line 75: | ||
{{familytree | | | | | | | | | | G01 | | | G02 | |G01=Consider [[pyelonephritis]]|G02=Consider alternative diagnosis such as; <br> [[Prostatitis]] <br> [[Urethritis]] <br> [[Renal abscess]]}} | {{familytree | | | | | | | | | | G01 | | | G02 | |G01=Consider [[pyelonephritis]]|G02=Consider alternative diagnosis such as; <br> [[Prostatitis]] <br> [[Urethritis]] <br> [[Renal abscess]]}} | ||
{{familytree | | | |,|-|-|-|v|-|-|^|.| | | |!| |}} | {{familytree | | | |,|-|-|-|v|-|-|^|.| | | |!| |}} | ||
{{familytree | | | H01 | | H02 | | H03 | | H04 | |H01=Acute uncomplicated pyelonephritis (Outpatient) <br> '''''Preferred regimen'''''<ref name="pmid24570249">{{cite journal| author=| title=Drugs for urinary tract infections. | journal=JAMA | year= 2014 | volume= 311 | issue= 8 | pages= 855-6 | pmid=24570249 | doi=10.1001/jama.2014.972 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=24570249 }} </ref><ref name="pmid21292654">{{cite journal| author=Gupta K, Hooton TM, Naber KG, Wullt B, Colgan R, Miller LG et al.| title=International clinical practice guidelines for the treatment of acute uncomplicated cystitis and pyelonephritis in women: A 2010 update by the Infectious Diseases Society of America and the European Society for Microbiology and Infectious Diseases. | journal=Clin Infect Dis | year= 2011 | volume= 52 | issue= 5 | pages= e103-20 | pmid=21292654 | doi=10.1093/cid/ciq257 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=21292654 }} </ref> <br> [[Ciprofloxacin]] (immediate release) 500mg bid x 7 days <br> [[Ciprofloxacin]] (extended release) 1000mg once daily x 7 days <br> OR <br> [[Levofloxacin]] 750mg once daily x 5 days OR <br> [[TMP-SMX]] 160/800mg bid x 14 days <br> '''''Alternative regimen''''': {{See main|Pyelonephritis medical therapy}}|H02=Complicated [[pyelonephritis]] (Inpatient) <br> '''''Preferred regimen''''' <br> IV [[Ceftriaxone]] 1g q24h <br> OR <br> IV [[Ciprofloxacin]] 400mg q12h <br> OR <br> IV [[Levofloxacin]] 750mg q24h <br> OR <br> IV [[Cefepime]] q12h <br> '''''Alternative regimen''''': {{See main|Pyelonephritis medical therapy}}|H03=Acute [[pyelonephritis]] in Pregnancy <br> '''''Preferred regimen''''' <br> IV [[Ceftriaxone]] 1g q24h <br> OR <br> IV [[Ampicillin]] 1-2g q6h <br> OR <br> IV [[Cefepime]] 1g q12h <br> '''''Alternative regimen''''': {{See main|Pyelonephritis medical therapy}}|H04=Is there urethral discharge?}} | {{familytree | | | H01 | | H02 | | H03 | | H04 | |H01=Acute uncomplicated pyelonephritis (Outpatient) <br> '''''Preferred regimen'''''<ref name="pmid24570249">{{cite journal| author=| title=Drugs for urinary tract infections. | journal=JAMA | year= 2014 | volume= 311 | issue= 8 | pages= 855-6 | pmid=24570249 | doi=10.1001/jama.2014.972 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=24570249 }} </ref><ref name="pmid21292654">{{cite journal| author=Gupta K, Hooton TM, Naber KG, Wullt B, Colgan R, Miller LG et al.| title=International clinical practice guidelines for the treatment of acute uncomplicated cystitis and pyelonephritis in women: A 2010 update by the Infectious Diseases Society of America and the European Society for Microbiology and Infectious Diseases. | journal=Clin Infect Dis | year= 2011 | volume= 52 | issue= 5 | pages= e103-20 | pmid=21292654 | doi=10.1093/cid/ciq257 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=21292654 }} </ref> <br> [[Ciprofloxacin]] (immediate release) 500mg bid x 7 days <br> [[Ciprofloxacin]] (extended release) 1000mg once daily x 7 days <br> OR <br> [[Levofloxacin]] 750mg once daily x 5 days OR <br> [[TMP-SMX]] 160/800mg bid x 14 days <br> '''''Alternative regimen''''': {{See main|Pyelonephritis medical therapy}}|H02=Complicated [[pyelonephritis]] (Inpatient) <br> '''''Preferred regimen''''' <br> IV [[Ceftriaxone]] 1g q24h <br> OR <br> IV [[Ciprofloxacin]] 400mg q12h <br> OR <br> IV [[Levofloxacin]] 750mg q24h <br> OR <br> IV [[Cefepime]] q12h <br> '''''Alternative regimen''''': {{See main|Pyelonephritis medical therapy}}|H03=Acute [[pyelonephritis]] in Pregnancy <br> '''''Preferred regimen''''' <br> IV [[Ceftriaxone]] 1g q24h <br> OR <br> IV [[Ampicillin]] 1-2g q6h <br> OR <br> IV [[Cefepime]] 1g q12h <br> '''''Alternative regimen''''': {{See main|Pyelonephritis medical therapy}}|H04=Is there [[urethral discharge]]?}} | ||
{{familytree | | | | | | | | | | | | | |,|-|^|-|.| | |}} | {{familytree | | | | | | | | | | | | | |,|-|^|-|.| | |}} | ||
{{familytree | | | | | | | | | | | | | I01 | | I02 | |I01=Yes|I02=No}} | {{familytree | | | | | | | | | | | | | I01 | | I02 | |I01=Yes|I02=No}} | ||
Line 80: | Line 98: | ||
[[Category:Resident survival guide]] | [[Category:Resident survival guide]] | ||
[[Category:Urology]] | [[Category:Urology]] | ||
[[Category:Nephrology]] | [[Category:Nephrology]] |
Latest revision as of 20:44, 5 March 2021
Urinary tract infection Resident Survival Guide |
---|
Overview |
Causes |
Diagnosis |
Treatment |
Do's |
Don'ts |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Ogheneochuko Ajari, MB.BS, MS [2] Iqra Qamar M.D.[3]
Overview
A urinary tract infection (UTI) is a bacterial infection that affects any part of the urinary tract.
Causes
Life Threatening Causes
- Life-threatening causes include conditions which may result in death or permanent disability within 24 hours if left untreated.
- Urinary tract infection does not have life threatening causes.
Common Causes
- Escherichia coli
- Klebsiella pneumonia
- Neisseria gonorrhea
- Proteus mirabilis
- Pseudomonas aeruginosa
- Staphylococcus saprophyticus
- Urinary catheterization
Management
Shown below is an algorithm depicting the initial approach to UTI.
Characterize the symptoms: ❑ Fever ❑ Dysuria ❑ Frequent urination ❑ Suprapubic pain ❑ Hematuria ❑ Vomiting ❑ Diarrhea ❑ Nausea ❑ Flank pain or back pain ❑ Weak urine stream ❑ Hesistancy ❑ Nocturia ❑ Chills ❑ Urethral discharge Obtain a detailed history: ❑ Use of urinary catheters ❑ Pregnancy ❑ Diabetes ❑ Female and sexually active ❑ Renal problems ❑ Menopausal ❑ Sickle cell disease ❑ Elderly ❑ Antibiotic use ❑ Urogynecologic surgery ❑ Urinary retention ❑ Urinary incontinence ❑ Anatomic malformations of the urinary tract ❑ Increased susceptibility to UTIs ❑ Allergies to latex condoms or spermicides | |||||||||||||||||||||||||||||||||||||||||
Examine the patient: ❑ Suprapubic tenderness ❑ Flank pain or costovertebral angle tenderness ❑ Tender prostate | |||||||||||||||||||||||||||||||||||||||||
Order tests: ❑ Urine culture ❑ Urinalysis ❑ Blood culture ❑ Abdominal CT ❑ Renal ultrasound scan ❑ Voiding cystourethrogram ❑ Intravenous pyelogram | |||||||||||||||||||||||||||||||||||||||||
Diagnosis and Treatment
An algorithm using symptoms/physical finding in diagnosis and treatment of UTIs.
UTI confirmed with urine culture (≥ 105 CFU/mL) + Pyuria | |||||||||||||||||||||||||||||||||||||||||||||
Is there suprapubic pain? | |||||||||||||||||||||||||||||||||||||||||||||
Yes | No | ||||||||||||||||||||||||||||||||||||||||||||
Consider Cystitis | Is there flank or back pain? | ||||||||||||||||||||||||||||||||||||||||||||
Acute uncomplicated cystitis Preferred regimen[1][2] TMP-SMX 160/800mg bid x 3 days OR Nitrofurantoin monohydrate/macrocrystals 100mg bid x 5-7 days OR Fosfomycin trometamol 3g once (single dose) OR Pivmecillinam 400mg bid x 5 days Alternative regimen: Template:See main | Complicated/Catheter-Associated Cystitis Preferred regimen For those who can tolerate ORALLY Ciprofloxacin 500mg PO bid x 5-14 days OR Ciprofloxacin Extended Release 1000mg daily x 5-14 days OR PARENTERALLY IV Levofloxacin 500mg OR IV Ceftriaxone 1g OR IV Ertapenem 1g Catheter-Associated UTI Remove catheter or intermittent catheterization Use same antibiotic therapy as above for CA-Cystitis Alternative regimen: Template:See main | Acute Cystitis in Pregnancy Preferred regimen Nitrofurantoin 100mg PO q12h x 5 days OR Amoxicillin-clavulanate 500mg PO q12h 3-7 days OR Fosfomycin 3g PO single dose Alternative regimen: TMP-SMX DS PO bid x 3 days only in 2nd trimester Template:See main | |||||||||||||||||||||||||||||||||||||||||||
Yes | No | ||||||||||||||||||||||||||||||||||||||||||||
Consider pyelonephritis | Consider alternative diagnosis such as; Prostatitis Urethritis Renal abscess | ||||||||||||||||||||||||||||||||||||||||||||
Acute uncomplicated pyelonephritis (Outpatient) Preferred regimen[1][2] Ciprofloxacin (immediate release) 500mg bid x 7 days Ciprofloxacin (extended release) 1000mg once daily x 7 days OR Levofloxacin 750mg once daily x 5 days OR TMP-SMX 160/800mg bid x 14 days Alternative regimen: Template:See main | Complicated pyelonephritis (Inpatient) Preferred regimen IV Ceftriaxone 1g q24h OR IV Ciprofloxacin 400mg q12h OR IV Levofloxacin 750mg q24h OR IV Cefepime q12h Alternative regimen: Template:See main | Acute pyelonephritis in Pregnancy Preferred regimen IV Ceftriaxone 1g q24h OR IV Ampicillin 1-2g q6h OR IV Cefepime 1g q12h Alternative regimen: Template:See main | Is there urethral discharge? | ||||||||||||||||||||||||||||||||||||||||||
Yes | No | ||||||||||||||||||||||||||||||||||||||||||||
Consider Urethritis For treatment of urethritis: Template:See main | Weak urine stream or hesitancy? | ||||||||||||||||||||||||||||||||||||||||||||
Yes | No | ||||||||||||||||||||||||||||||||||||||||||||
Consider Prostatitis | Renal USS to rule out renal abscess (drainage + antibiotics for renal abscess) Other investigations (Abdominal CT, VSUG, for anatomic abnormality or obstructions | ||||||||||||||||||||||||||||||||||||||||||||
Do's
- TMP-SMX should only be used in the second trimester of pregnancy.
Dont's
- Don't use fluoroquinolones empirically for treatment of acute uncomplicated cystitis.[1]
- Do not give fluoroquinolones in pregnancy.
- Don't give TMP-SMX in first trimester or near term of pregnancy.
References
- ↑ 1.0 1.1 1.2 "Drugs for urinary tract infections". JAMA. 311 (8): 855–6. 2014. doi:10.1001/jama.2014.972. PMID 24570249.
- ↑ 2.0 2.1 Gupta K, Hooton TM, Naber KG, Wullt B, Colgan R, Miller LG; et al. (2011). "International clinical practice guidelines for the treatment of acute uncomplicated cystitis and pyelonephritis in women: A 2010 update by the Infectious Diseases Society of America and the European Society for Microbiology and Infectious Diseases". Clin Infect Dis. 52 (5): e103–20. doi:10.1093/cid/ciq257. PMID 21292654.